Evolent Health Inc (EVH) — Capital Reinvestment Ratio

Latest as of December 2025: 0.16x

Evolent Health Inc (EVH) has a Capital Reinvestment Ratio of 0.16x as of December 2025, meaning it reinvests 0% of its operating cash flow ($48.80 Million) in capital expenditures ($7.76 Million). Check Evolent Health Inc (EVH) tangible equity ratio to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.16x
Capex / Operating Cash Flow

Operating Cash Flow

$48.80 Million
USD

Capital Expenditures

$7.76 Million
USD

Data as of

Dec 2025
Most recent filing

Evolent Health Inc Capital Reinvestment Ratio (2021–2025)

This chart tracks Evolent Health Inc's Capital Reinvestment Ratio across 4 annual periods. For the full cash flow conversion analysis, see EVH operating cash flow.

Annual Capital Reinvestment Ratio for Evolent Health Inc (2021–2025)

Year-by-year Capital Reinvestment Ratio for Evolent Health Inc from 2021 to 2025. See Evolent Health Inc (EVH) free cash flow to measure how efficiently the company converts operating cash flow to free cash.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 0.88x $38.84 Million $34.09 Million ▼ -33.8%
2024 1.33x $18.77 Million $24.89 Million ▲ +558.0%
2023 0.20x $142.58 Million $28.75 Million ▼ -68.7%
2021 0.64x $38.75 Million $24.98 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow